ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,377.60
      -0.19%
      Dow Jones
      42,208.22
      0.00%
      Brent Oil
      73.215
      -1.80%
      Bitcoin
      63,791.51
      -0.74%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Fortress Biotech Inc (FBIO) Quote

      Fortress Biotech Inc

      Fortress Biotech Inc (FBIO)

      NASDAQ
      1.39
      -0.04
      (-2.80%)
      Closed September 24 4:00PM
      Delayed by 15 minutes
      1.4475
      0.0575
      ( 4.14% )
      Pre Market: 8:00AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.4475
      Bid
      1.42
      Ask
      1.45
      Volume
      2,781
      0.00 Day's Range 0.00
      1.24 52 Week Range 5.2485
      Market Cap
      33.023M
      Previous Close
      1.39
      Open
      -
      Last Trade
      100
      @
      1.4475
      (formt)
      Last Trade Time
      08:00:03
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      395,683
      Shares Outstanding
      22,813,954
      Dividend Yield
      -
      PE Ratio
      -0.46
      Earnings Per Share (EPS)
      -3.01
      Revenue
      84.51M
      Net Profit
      -68.67M

      About Fortress Biotech Inc

      Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.fortressbiotech.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIO. The last closing price for Fortress Biotech was $1.39. Over the last year, Fortress Biotech shares have traded in a share price range of $ 1.24 to $ 5.2485.

      Fortress Biotech currently has 22,813,954 shares outstanding. The market capitalization of Fortress Biotech is $31.71 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.46.

      Ask ADVFN Intelligence (AI)

      FBIO Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      24 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      24 hours ago

      Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

      MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to...

      September 20 2024
      GlobeNewswire Inc.

      Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

      SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...

      September 09 2024
      GlobeNewswire Inc.

      Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

      MIAMI, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance...

      September 04 2024
      GlobeNewswire Inc.

      Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

      SCOTTSDALE, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...

      September 04 2024
      GlobeNewswire Inc.

      Avenue Therapeutics to Participate in Upcoming Investor Conferences

      MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

      September 03 2024
      GlobeNewswire Inc.

      Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

      PDUFA goal date of November 4, 2024 for DFD-29 for the treatment of inflammatory lesions and erythema of rosacea in adults FDA accepted Biologics License Application resubmission for cosibelimab...

      August 13 2024
      GlobeNewswire Inc.

      Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

      New Drug Application for DFD-29 to treat rosacea under FDA review; PDUFA goal date of November 4, 2024 Total revenues for the second quarter ended June 30, 2024 were $14.9 million, a 14% increase...

      August 12 2024
      GlobeNewswire Inc.

      Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

      - Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of 2024 – - Raised $4.4 million in gross...

      August 09 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.4625-24.21465968591.912.041.35517432021.50213546CS
      4-0.5925-29.04411764712.042.091.3556157231.59618238CS
      12-0.2425-14.3491124261.692.891.3553956831.83818678CS
      26-0.4725-24.6093751.922.891.3552864871.84097454CS
      52-3.0525-67.83333333334.55.24851.244218092.23832865CS
      156-52.2525-97.304469273753.757.151.2450189314.12239398CS
      260-20.3025-93.344827586221.7591.51.2464506334.87246167CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BREABrera Holdings PLC
      $ 1.20
      (64.38%)
      		2.49M
      OCTOEightco Holdings Inc
      $ 3.65
      (46.59%)
      		8.38M
      ELYMEliem Therapeutics Inc
      $ 8.15
      (24.24%)
      		1.06M
      MSGMMotorsport Games Inc
      $ 1.35
      (22.73%)
      		5.11M
      TOIOncology Institute Inc
      $ 0.349
      (20.10%)
      		2
      VTNRVertex Energy Inc
      $ 0.1572
      (-56.45%)
      		3.28M
      BNZIBanzai International Inc
      $ 5.49
      (-33.37%)
      		417.12k
      SFIXStitch Fix Inc
      $ 2.80
      (-25.33%)
      		182.28k
      THTarget Hospitality Corporation
      $ 7.15
      (-24.26%)
      		123.12k
      PLUSePlus inc
      $ 78.00
      (-20.36%)
      		5
      STSSSharps Technology Inc
      $ 0.152
      (-10.85%)
      		13.95M
      ELABElevai Labs Inc
      $ 0.1072
      (4.08%)
      		9.11M
      OCTOEightco Holdings Inc
      $ 3.65
      (46.59%)
      		8.38M
      SEELSeelos Therapeutics Inc
      $ 0.3217
      (7.59%)
      		7.33M
      MSGMMotorsport Games Inc
      $ 1.35
      (22.73%)
      		5.11M

      FBIO Discussion

      View Posts
      rbl100 rbl100 5 days ago
      They are probably a shorter. The lowest form of humanity. These people bankrupt companies and kill jobs for others who work in these companies that get their stocks shorted. They thrive on wickedness and evil. And get joy and jollies from hurting others.
      👍️0
      investtemp investtemp 3 weeks ago
      If your book only contained all your post on I hub it would be about 500 pages
      👍️0
      Monksdream Monksdream 3 weeks ago
      FBIO 10 day hourly
      👍️0
      Monksdream Monksdream 1 month ago
      FBIO 10Q due AUGUST 19
      👍️0
      Monksdream Monksdream 2 months ago
      FBIO under $3
      👍️0
      Monksdream Monksdream 3 months ago
      FBIO under $2
      👍️0
      Monksdream Monksdream 5 months ago
      FBIO under $2
      👍️0
      Monksdream Monksdream 6 months ago
      FBIO under $2
      👍️0
      triannual triannual 8 months ago
      Buy order @ $1.40 / 1000 shares. GLTA!
      👍️0
      rbl100 rbl100 9 months ago
      Not exactly certain, but I am holding for the results. I almost sold some shares for some pocket money but held off. Don't want to miss any news. My luck is I sell and then news hits and it takes off. My CA is $1.29 per share. No skin off my back with the drop.
      👍️0
      conix conix 9 months ago
      At some point, these biotechs need to prove they have promising drug candidates in clinical trials and are not just good at raising capital
      👍️ 1
      Sierra20 Sierra20 9 months ago
      $11 million offering. Ouch.
      👍️0
      Sierra20 Sierra20 9 months ago
      1/3 PDUFA is no longer valid.
      👍️0
      rabbit67 rabbit67 9 months ago
      When is next fda news jan19?
      👍️0
      1hot toddy 1hot toddy 9 months ago
      yahoo finance says $41 price in 1 year $$$$$$$$$$$
      👍️0
      rbl100 rbl100 10 months ago
      This thing could be like Bill Bixby. You know the 1978 series whereby just before he gets extreme stress and anger. Holding for next year+++.
      👍️0
      rbl100 rbl100 10 months ago
      Check it out now. Glad I held. Very low float. Nice gem I was tipped off about and looking forward to the FDA approvals.
      👍️0
      1hot toddy 1hot toddy 10 months ago
      MONSTER BIG BUYS 15000 AND 14000 SHARES. $30K EACH BUY
      👍️0
      rbl100 rbl100 10 months ago
      Shorts kept it in check. Profit takers made it drop. No volume for them to brag about. So the drop is normal business as usual. If you see a large drop AND very large abnormal volume... that is when to worry. Remember insiders bought this stock at an average of $9.00 + per share pre R/S. They know it is going into the $40's next year... Nice 20 bagger.
      👍️ 1
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO PUSHING UP IN PRE, LETS SEE THAT 3 DOLLA
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      Stick to your hobby of posting 52 week high and 52 week lows chief.
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO HOLY FUC!!!
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO FAB!!!
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO MONSTER
      👍️0
      rbl100 rbl100 10 months ago
      More than the float traded today. Unless I am seeing things LOL.
      👍️ 1
      TrendTrade2016 TrendTrade2016 10 months ago
      Chief keep posting your 52 week highs and lows. Get a better hobby
      👍️0
      rbl100 rbl100 10 months ago
      Then don't waste your time here. No one needs anyone to protect them from themselves. We have enough with gubberment. Speaking of which should be abolished.
      👍️0
      Monksdream Monksdream 10 months ago
      It’s a wash trade event
      You’re pushing the envelope
      👍️0
      rbl100 rbl100 10 months ago
      That is fine, but this one is looking promising as time goes on. Got to be in it to win it. FDA rubber stamps approvals these days. Years ago it was a different story. They relaxed most standards, so not worried at all. late 2020 and 2021 proved it with the CLOVER schots. FDA is nothing but a paid co-conspirator to bad. So use it to your benefit.
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO...NEXT STOP 2.27
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO...MONSTER
      👍️0
      Monksdream Monksdream 10 months ago
      Biomed stocks and med device stocks are tricky
      The sectors have a combined count of close to a thousand
      Not all, in fact no more than 5% will be long winners
      👍️0
      rbl100 rbl100 10 months ago
      Yes indeed. Better than CVM where I have been stuck since 2008 or so. Still down over 80% of my initial investment of $900 or thereabouts.
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO...HERE WE GO
      👍️0
      Monksdream Monksdream 10 months ago
      Lucky you
      👍️0
      TrendTrade2016 TrendTrade2016 10 months ago
      FBIO...ON THE MOVE
      👍️0
      rbl100 rbl100 10 months ago
      Yep and I bought up shares. Way lower than company owners bought at for sure.
      👍️0
      Monksdream Monksdream 10 months ago
      FBIO new 52 week low
      👍️0
      Disquisition Disquisition 11 months ago
      UNBELIEVABLE DUMPING
      👍️0
      Monksdream Monksdream 11 months ago
      FBIO new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      FBIO new 52 wweek low
      👍️0
      Monksdream Monksdream 1 year ago
      FBIO new 52 week low
      👍️0
      Pisd Pisd 1 year ago
      Are you taunting? lol ...
      👍️0
      Monksdream Monksdream 1 year ago
      FBIO new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      FBIO new 52 week low
      👍️0
      Pisd Pisd 1 year ago
      https://ih.advfn.com/stock-market/NASDAQ/fortress-biotech-FBIO/stock-news/91811180/fortress-biotech-reports-second-quarter-2023-finan
      👍️0
      Pisd Pisd 1 year ago
      Hi my friend..adding FBIO$ today yr low..tough crowd, gl...
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      green
      👍️0
      The Night Stalker The Night Stalker 1 year ago
      cheap
      👍️0
      Spicknspan Spicknspan 2 years ago
      Has FBIO gotten a NASDAQ warning letter yet?




      I like the company, but needs to get over $1.00
      👍️0

      Your Recent History

      NASDAQ
      FBIO
      Fortress Biotech
      Delayed Upgrade Clock